FDA Inspection 1147263 — CGG Medical Inc.

CGG Medical Inc. — FEI 3014250051

The FDA completed an inspection of CGG Medical Inc. on July 21, 2021 in Tallahassee, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 21, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tallahassee, FL (United States)

Citations

IDCFRDescription
1233821 CFR 1271.180(b)Review and approval-responsible person